South and Central America Cell Therapy Market
Cell therapy is a procedure where living and intact cells are injected, implanted, or grafted into the patient's body. This technology relies on replacing dysfunctional cells with healthy functioning ones. Cells mainly used for such advanced therapies are stem cells, because of their ability to differentiate into the specific cells required for repairing damaged or defective tissues or cells. Moreover, cell therapy also has applications in the development of regenerative medicines.
The South and Central America cell therapy market is expected to reach US$ 415.8 million by 2027 from US$ 271.9 million in 2019; it is anticipated to grow at a CAGR of 5.5% during 2019–2027. Factors such as increasing prevalence of chronic diseases, rising adoption of regenerative medicines and increasing number of approvals for cell-based therapies are expected to boost the growth of the cell therapy market in the coming years. However, the market is likely to get impacted by the risk factor such as high cost of cell therapy manufacturing, during the forecast period.
COVID-19 pandemic has become the most significant challenge across the South and Central America region. Countries such as Brazil and Argentina have also registered a significant number of positive patients. For instance, in Brazil, the number of cases increased to about 8.82 million, with 216,000 deaths reported as per the world meter till date. With the outbreak of second wave COVID-19, there has been an increasing number of cases in the Latin American countries. Currently, the country is rapidly increasing its clinical programs to fight against the novel corona virus. There has been a rising focus on cell and gene therapies. For instance, Brazilian Association of Hematology, Hemotherapy and Cellular Therapy have constituted a panel of experts to carefully examine and review the use of cellular therapies for the treatment of COVID 19.
The scope of the South and Central America cell therapy market includes therapy type, product, technology, applications, end user and countries. In terms of therapy type, the allogeneic segment accounted for the largest share of the South and Central America cell therapy market in 2019. In terms of product, the consumables segment accounted for the largest share of the South and Central America cell therapy market in 2019. The viral vector technology segment accounted for the largest share of the South and Central America cell therapy market, by technology, in 2019. In terms of applications, the Oncology segment accounted for the largest share of the South and Central America cell therapy market in 2019. In terms of end user, the Research Institutes segment accounted for the largest share of the South and Central America cell therapy market in 2019.
Several major primary and secondary sources associated with the South and Central America cell therapy market report are the World Health Organization (WHO), Food and Drug Administration (FDA), Centers of Disease Control and Prevention (CDC), American Cancer Society, and Brazil National Health Surveillance Agency or ANVISA, Brazilian Association of Hematology, Hemotherapy and Cellular Therapy and among others.
The South and Central America Cell Therapy Market is valued at US$ 271.9 Million in 2019, it is projected to reach US$ 415.8 Million by 2027.
As per our report South and Central America Cell Therapy Market, the market size is valued at US$ 271.9 Million in 2019, projecting it to reach US$ 415.8 Million by 2027. This translates to a CAGR of approximately 5.5% during the forecast period.
The South and Central America Cell Therapy Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South and Central America Cell Therapy Market report:
The South and Central America Cell Therapy Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South and Central America Cell Therapy Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South and Central America Cell Therapy Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For South and Central America Cell Therapy Market
